Abogen Biosciences is a leading biotech company dedicated to safeguarding global health by bringing an array of transformative therapies through innovative mRNA science and technology. Leveraging a proprietary, cutting-edge end-to-end mRNA technology platform, the company has built a portfolio of mRNA-based products focused on immuno-oncology, protein replacement therapies and infectious diseases.